Oct 3 (Reuters) - Fluicell AB FLUIC.ST :
* APPOINTS NEW CEO AND INITIATES TARGETED ORGANIZATIONAL
CHANGES
TO ACCELERATE DEVELOPMENT OF TYPE 1 DIABETES THERAPY
* ANNOUNCES THAT VICTOIRE VIANNAY, AFTER CONSULTATION WITH
THE
BOARD OF DIRECTORS, WILL STEP DOWN AS CEO
* BOD HAS APPOINTED THE CURRENT CHIEF INNOVATION OFFICER,
CAROLINA
TRKULJA, AS THE NEW CEO
* VIANNAY WILL ASSUME THE POSITION AS CEO ON OCTOBER 9, 2023
* TRKULJA WILL TAKE UP THE POSITION AS CEO ON OCTOBER 9,
2023
* KEY OBJECTIVE OF RESTRUCTURING IS TO STRENGTHEN CO'S
FINANCIAL
POSITION, INCREASE SHAREHOLDER VALUE
* COSTS RELATED TO THE RESTRUCTURING WILL BE CHARGED TO
EARNINGS
FOR Q4 2023
* RESTRUCTURING IS EXPECTED TO COVER ABOUT HALF OF CO'S
SERVICES
AND IS EXPECTED TO RESULT IN ANNUAL SAVINGS CORRESPONDING TO 50%
REDUCTION IN CO'S COSTS
Source text for Eikon: ID:nWkr2hfSYP
Further company coverage: FLUIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))